Phd Candidate
CurrentThe main project of this PhD is focused on using a neutrophil-stimulating, bi-specific antibody as a vehicle for organic, immuno-active payloads in order to treat a variety of cancers in pre-clinical models. This involves molecular techniques such as bi-specific antibody design/production, genetic cloning, binding- and ELISA assays; as well as functional cellular techniques such as Antibody-Dependant Cellular Cytotoxicity/Phagocytosis (ADCC/ADCP) and chemotaxis assays. Passing these in vitro tests will lead to possible candidates being tested in a pre-clinical tumor mouse model. In the group of Prof. Dr. Marjolein van Egmond at the department of Molecular Cell Biology and Immunology (MCBI) situated at the Amsterdam UMC, location VUmc.